PENGARUH MULTIPLE MICRONUTRIENT POWDER TERHADAP PERTUMBUHAN ANAK DENGAN ANEMIA USIA 6-59 BULAN

2020 ◽  
Vol 9 (2) ◽  
Author(s):  
Prastiwi Putri Basuki
Keyword(s):  
Randomized Control Trial ◽  
Z Score ◽  
Trace Mineral ◽  
Micronutrient Powder ◽  
Multiple Micronutrient ◽  
Randomized Control ◽  
Multiple Micronutrient Powder

Latar belakang: Kesehatan anak tergantung interaksi antara genetika danfaktor eksogenous seperti kecukupan gizi, kesehatan lingkungan, interaksi sosial dan stimulasi. Hampir dua pertiga kematian anak di dunia secara langsung dan tidak langsung berhubungan  dengan  defisiensi gizi. Kurang energi protein dan defisiensi mikronutrien meningkatkan risiko kematian karena penyakit seperti anemia, gastroenteritis, pneumonia dan campak. Vitamin dan trace mineral dibutuhkan untuk produksi berbagai macam enzim, hormon, dan mediator biokimiawi untuk mengatur proses biologi. Mikronutrien juga dibutuhkan untuk meningkatkan pertumbuhan fisik, kematangan seksual dan perkembangan syaraf.Tujuan: Penelitian ini bertujuan untuk menganalisis pengaruh MultipleMicronutrient Powder Terhadap Pertumbuhan Anak Dengan Anemia Usia 6-59 Bulan.Metode: Metode penelitian adalah Randomized Control Trial yang dilakukan pada bulan Maret – Mei 2013 di Kecamatan Polanharjo Kabupaten Klaten. Anak dengan anemia usia 6-59 bulan dipilih secara random , dikelompokkan menjadi dua kelompok yaitu kelompok yang diberi Multiple Micronutrient Powder dan kelompok lain diberi plasebo. Keduanya diberi perlakuan selama 12 minggu. Berat Badan dan tinggi badan   diukur sebelum dan sesudah perlakuan. Hasil dianalisis dengan menggunakan analisis t-test.Hasil: Anak dengan anemia yang diberi Multiple Micronutrient Powder terjadipeningkatan rata-rata z-score pada indeks TB/U (p=0.829), BB/U (p=0.906), dan BB/TB (p=0.996) walaupun secara statistik tidak signifikan.

scholarly journals Pengaruh Multiple Micronutrient Powder Terhadap Kejadian Infeksi Saluran Pernapasan Akut Pada Anak Usia 6-59 Bulan Dengan Anemia

2019 ◽  
Vol 6 (2) ◽  
pp. 592
Author(s):  
Murgi Handari
Keyword(s):  
Randomized Control Trial ◽  
Micronutrient Powder ◽  
Multiple Micronutrient ◽  
Randomized Control ◽  
Multiple Micronutrient Powder

Anak Balita merupakan kelompok usia yang rentan terhadap gizi dan kesehatan. Pada masa ini daya tahan tubuh anak masih belum kuat, sehingga risiko anak menderita penyakit infeksi lebih tinggi. Salah satu penyakit infeksi yang sering terjadi pada Anak balita adalah Infeksi Saluran Pernafasan Akut (ISPA). Multiple Micronutrient Powder  merupakan multimineral yang diberikan pada balita untuk membantu tumbuh kembang balita secara optimal, meningkatkan daya tahan tubuh, meningkatkan nafsu makan, mencegah anemia dan mencegah kekurangan zat gizi. Penelitian ini bertujuan untuk menganalisis pengaruh Multiple Micronutrient Powder Terhadap Kejadian ISPA Anak Dengan Anemia Usia 6-59 Bulan. Metode penelitian adalah Randomized Control Trial dengan sampel Anak dengan anemia usia 6-59 bulan dipilih secara random. Sampel dikelompokkan menjadi dua kelompok yaitu kelompok yang diberi Multiple Micronutrient Powder dan kelompok lain diberi plasebo. Keduanya diberi perlakuan selama 12 minggu. Kejadian ISPA diobservasi sebelum dan sesudah perlakuan. Berdasarkan analisis regresi linier ganda didapatkan hasil bahwa balita yang diberi Multiple Micronutrient Powder menurun kejadian ISPA sebesar 0,076 dibandingkan yang diberi plasebo, walaupun secara statistik tidak signifikan (p=0,455). Pemberian Multiple Micronutrient Powder pada balita dengan anemia menurunkan kejadian ISPA, meskipun secara statistik tidak signifikan.

scholarly journals Effect of Fortification with Multiple Micronutrient Powder on the Prevention and Treatment of Iron Deficiency and Anaemia in Brazilian Children: A Randomized Clinical Trial

Nutrients ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 2160
Author(s):  
Malaine Morais Alves Machado ◽  
Mirella de Paiva Lopes ◽  
Raquel Machado Schincaglia ◽  
Paulo Sérgio Sucasas da Costa ◽  
Alexandre Siqueira Guedes Coelho ◽  
...  
Keyword(s):  
Iron Deficiency ◽  
Serum Ferritin ◽  
Transferrin Receptor ◽  
Ferrous Sulfate ◽  
Soluble Transferrin Receptor ◽  
Standard Drug ◽  
Micronutrient Powder ◽  
Prevention And Treatment ◽  
Multiple Micronutrient ◽  
Multiple Micronutrient Powder

Fortification with multiple micronutrient powder has been proposed as a public health intervention able to reduce micronutrient deficiencies in children. Our objective was to compare the effectiveness of fortification with multiple micronutrient powder with drug supplementation in the prevention and treatment of iron deficiency and anaemia. This was a cluster trial with anemic and non-anaemic children between six and 42 months old, in randomization data. Non anaemic children received fortification with multiple micronutrient powder or standard drug supplementation of ferrous sulfate associated with folic acid in a prevention dose. Anaemic children who were randomized to receive multiple micronutrient powder also received the recommended iron complementation for anaemia treatment. A total of 162 children were evaluated. The prevalence of anaemia decreased from 13.58 to 1.85%. Iron deficiency decreased from 21.74% to 7.89% (by serum ferritin) and iron deficiency decreased from 66.81 to 38.27% (by soluble transferrin receptor). No difference was identified between interventions for hemoglobin (p = 0.142), serum ferritin (p = 0.288), and soluble transferrin receptor (p = 0.156). Fortification with multiple micronutrient powder was effective in preventing iron deficiency and anaemia in children aged six to 48 months. In anaemic children; it was necessary to supplement the dose of multiple micronutrient powder with ferrous sulfate.

scholarly journals Multiple Micronutrient Powder Reduces Vitamin E Deficiency in Brazilian Children: A Pragmatic, Controlled Clinical Trial

Nutrients ◽  
2019 ◽  
Vol 11 (11) ◽  
pp. 2730 ◽  
Author(s):  
Lina M. C. Lobo ◽  
Raquel M. Schincaglia ◽  
Maria do Rosário G. Peixoto ◽  
Maria Claret C. M. Hadler
Keyword(s):  
Clinical Trial ◽  
Vitamin E ◽  
Intervention Group ◽  
Outcome Variable ◽  
Controlled Clinical Trial ◽  
Vitamin E Deficiency ◽  
Micronutrient Powder ◽  
Multiple Micronutrient ◽  
Multiple Micronutrient Powder ◽  
Brazilian Children

Multiple micronutrient powder supplementation is a health promotion strategy, but data on its effectiveness regarding vitamin E are rare. The objective was to evaluate the impact of home fortification with powdered micronutrients on α-tocopherol concentrations, growth, and inflammation in Brazilian children aged 6–15 months. This is a pragmatic, controlled clinical trial, in which the intervention group received micronutrient powder sachets for up to 3 months. Vitamin E deficiency was considered when α-tocopherol was less than 11.6 µmol/L. The Poisson regression model was used to estimate adjusted values for prevalence ratios (PR) for the outcome variable. A total of 224 children participated in the study. The intervention group had a higher median α-tocopherol level (17.2 versus 3.6 µmol/L; p < 0.001) and an 82.0% reduction in the prevalence of vitamin deficiency (PR = 0.18; 95% CI 0.11–0.30) when compared with the control group. Consumption of multiple micronutrients in powder increases serum α-tocopherol concentrations, promotes better linear growth, and reduces morbidity in children.

scholarly journals The impact of home fortification with multiple micronutrient powder on vitamin A status in young children: A multicenter pragmatic controlled trial in Brazil

2016 ◽  
Vol 13 (4) ◽  
Author(s):  
Lara Livia Santos Silva ◽  
Rosângela Aparecida Augusto ◽  
Daniela Cardoso Tietzmann ◽  
Leopoldina Augusta Souza Sequeira ◽  
Maria Claret Costa Monteiro Hadler ◽  
...  
Keyword(s):  
Young Children ◽  
Vitamin A ◽  
Controlled Trial ◽  
Vitamin A Status ◽  
Micronutrient Powder ◽  
Multiple Micronutrient ◽  
Multiple Micronutrient Powder ◽  
The Impact ◽  
Home Fortification

scholarly journals Effects of Zinc Alone versus Zinc-Containing Multiple Micronutrient Powder on Insulin-Like Growth Factor 1 (IGF1) and IGF Binding Protein-3 (IGFBP3) in Laotian Children (OR07-05-19)

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Maxwell Barffour ◽  
Robin Berstein ◽  
Guy-Marino Hinnouho ◽  
K Ryan Wessells ◽  
Charles Arnold ◽  
...  
Keyword(s):  
Growth Factor ◽  
Binding Protein ◽  
Physical Growth ◽  
Insulin Like Growth Factor ◽  
Micronutrient Powder ◽  
Multiple Micronutrient ◽  
Igf Binding ◽  
Multiple Micronutrient Powder ◽  
Igf Binding Protein ◽  
Parent Trial

Abstract Objectives To assess a) the impact of daily preventive zinc tablets (7 mg; PZ), multiple micronutrient powder (10 mg zinc, 6 mg iron and 13 other micronutrients; MNP) or placebo on Insulin-like Growth Factor 1 (IGF1), IGF Binding Protein 3 (IGFBP3) and IGF1 bioavailability (indexed by molar IGF1: IGFBP3 ratio), among Laotian children aged 6–23 mo; b) potential effect modification by baseline physical growth status. Methods Plasma samples from 419 children participating in the parent trial (n = 3407) were collected at baseline and after ∼9 mo (endline). Determination of IGF1 and IGFBP3 were done via an automated chemiluminescent assay. Linear regression models were used to assess main and modifying effects of PZ and MNP on IGF1 and IGFBP3, controlling for age, sex, district and baseline values of each biomarker. Results The parent trial found no overall treatment effects on physical growth. In this subgroup, mean age at baseline was 14.2 ± 5.1 mo and ∼38% were stunted. IGF1 and IGFBP3 at baseline were 45.9 ng/ml and 2143.0 ng/ml, respectively. At endline, geometric mean IGF1 (∼39.0–39.2 ng/ml; P = 0.99), IGFBP3 (2038–2076 ng/ml; P = 0.83) and molar IGF1: IGFBP3 ratio (0.071–0.073; P = 0.74) did not differ by group. Baseline weight-for-age z-score (WAZ) modified the treatment effect on IGFBP3 (p for interaction = 0.05) and molar IGF1: IGFBP3 (p for interaction = 0.04). In non-underweight children (WAZ ≥ -2), mean IGFBP3 in the PZ group (2000 ng/ml) was significantly lower than in the placebo (2148 ng/ml; P = 0.03) and MNP (2157 ng/ml; P = 0.03) groups. In underweight children, however, the IGFBP3 in the PZ group (2039 ng/ml) was higher than the placebo (1774 ng/ml; P = 0.05) but not the MNP (1881 ng/ml; P = 0.15) group. PZ (relative to placebo and MNP) appeared to reduce the bioavailability of IGF1 in underweight children, while increasing IGF1 bioavailability in non-underweight children (p interaction = 0.04). Conclusions IGF1 in this population did not respond to PZ or MNP. PZ (relative to placebo and MNP) was associated with higher endline IGFBP3 concentrations in underweight children but lower values in non-underweight children. These results suggest that PZ affected activity in the GH-IGF axis in these children, but additional evidence is needed to understand long term implications for growth in this population. Funding Sources By The Thrasher Research Fund, with support from the Mathile Institute for the Advancement of Human Nutrition, Nutrition International and the Bill & Melinda Gates Foundation.

Sign in / Sign up

Export Citation Format

Share Document